Human Xtensions Ltd Cash Flow Conversion Efficiency
Human Xtensions Ltd cash flow conversion efficiency. Based on the latest financial reports, Human Xtensions Ltd (HUMX) has a cash flow conversion efficiency ratio of -0.626x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-2.06 Million ≈ $-5.51K USD) by net assets (ILA3.29 Million ≈ $8.81K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Human Xtensions Ltd (2018–2024)
Cash flow conversion efficiency of Human Xtensions Ltd from 2018 to 2024. This chart illustrates how Human Xtensions Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Human Xtensions Ltd (HUMX) share price today for real-time trading data and today's change.
Human Xtensions Ltd Cash Flow Conversion Ratio Explained
Human Xtensions Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Human Xtensions Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Human Xtensions Ltd ranked by their cash flow conversion efficiency. Also see market value of Human Xtensions Ltd for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
RPM Automotive Group Ltd
AU:RPM
|
0.023x |
|
SRT Marine Systems plc
LSE:SRT
|
-0.305x |
|
Literacy Capital PLC
LSE:BOOK
|
-0.006x |
|
Haoxi Health Technology Limited Class A Ordinary Shares
NASDAQ:HAO
|
-0.142x |
|
Clean & Carbon Energy S.A.
WAR:CCE
|
-0.044x |
|
Celtic PLC
LSE:CCP
|
-0.038x |
|
Downing Renewables & Infrastructure Trust PLC
LSE:DORE
|
0.022x |
|
Martello Technologies Group Inc
V:MTLO
|
0.039x |
Annual Cash Flow Conversion Efficiency for Human Xtensions Ltd (2018–2024)
The table below shows the annual cash flow conversion efficiency of Human Xtensions Ltd from 2018 to 2024. Review HUMX financial flexibility score to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ILA2.91 Million ≈ $7.81K |
ILA-20.84 Million ≈ $-55.88K |
-7.156x | -444.52% |
| 2023-12-31 | ILA26.11 Million ≈ $69.99K |
ILA-34.31 Million ≈ $-91.97K |
-1.314x | -94.54% |
| 2022-12-31 | ILA61.78 Million ≈ $165.63K |
ILA-41.73 Million ≈ $-111.88K |
-0.675x | -67.38% |
| 2021-12-31 | ILA104.53 Million ≈ $280.25K |
ILA-42.19 Million ≈ $-113.10K |
-0.404x | -120.35% |
| 2020-12-31 | ILA148.82 Million ≈ $398.99K |
ILA-27.26 Million ≈ $-73.08K |
-0.183x | +86.26% |
| 2019-12-31 | ILA20.43 Million ≈ $54.77K |
ILA-27.24 Million ≈ $-73.03K |
-1.333x | +19.80% |
| 2018-12-31 | ILA15.51 Million ≈ $41.57K |
ILA-25.78 Million ≈ $-69.12K |
-1.663x | -- |
About Human Xtensions Ltd
Human Xtensions Ltd., a medical robotics company, develops, manufactures, markets, and sells modular medical device for minimally invasive surgical operations in Israel. The company offers HandX, a handheld smart laparoscopy solution for use in laparoscopic surgeries; fenestrated grasper; monopolar hook; monopolar spatula; monopolar scissors; self-righting needle holder; and needle holder. Human … Read more